Published in J Korean Surg Soc on December 26, 2012
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks | NCT01037049
Oncologic outcomes in rectal cancer with close distal resection margins: a retrospective analysis. Ann Surg Treat Res (2015) 0.75
Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med (2004) 25.68
Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet (2005) 14.64
Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet (1986) 10.07
The mesorectum in rectal cancer surgery--the clue to pelvic recurrence? Br J Surg (1982) 8.69
Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol (2007) 7.75
Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol (2009) 5.69
Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol (2010) 5.51
Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial. Lancet (2004) 4.65
Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg (2004) 3.50
Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol (2005) 2.91
Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg (2002) 2.89
Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study. J Clin Oncol (2005) 2.77
Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol (2003) 2.69
Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol (1999) 2.67
Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum (2004) 2.52
An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer. Ann Surg Oncol (2008) 2.31
Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg (2010) 2.23
Circumferential resection margin as a prognostic factor in rectal cancer. Br J Surg (2009) 2.17
Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum (1998) 2.09
Neoadjuvant therapy for rectal cancer: the impact of longer interval between chemoradiation and surgery. J Gastrointest Surg (2010) 2.03
Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann Surg (2009) 1.83
Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev (2007) 1.80
The relationship between the extent of distal clearance and survival and local recurrence rates after curative anterior resection for carcinoma of the rectum. Ann Surg (1983) 1.63
Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg (1995) 1.54
A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. Ann Surg Oncol (2011) 1.54
Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers. Ann Surg (2008) 1.51
Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection. Ann Surg (2009) 1.48
Short-term outcomes of laparoscopic total mesorectal excision following neoadjuvant chemoradiotherapy. Surg Endosc (2009) 1.44
Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial. Ann Surg (2011) 1.43
Complete clinical response after preoperative chemoradiation in rectal cancer: is a "wait and see" policy justified? Dis Colon Rectum (2007) 1.36
'Close shave' in anterior resection. Br J Surg (1990) 1.33
The rationale for preservation of the anal sphincter in patients with low rectal cancer. Br J Surg (1984) 1.26
Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma. Dis Colon Rectum (2003) 1.25
Distal spread of rectal cancer and optimal distal margin of resection for sphincter-preserving surgery. Cancer (1995) 1.23
Laparoscopic versus open surgery for extraperitoneal rectal cancer: a prospective comparative study. Surg Endosc (2005) 1.20
Delaying surgery after neoadjuvant chemoradiotherapy for rectal cancer may reduce postoperative morbidity without compromising prognosis. Br J Surg (2008) 1.16
Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum (1998) 1.16
Alternative clinical end points in rectal cancer--are we getting closer? Ann Oncol (2006) 1.09
Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer. Br J Surg (2003) 1.09
Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial. Radiother Oncol (2007) 1.08
Morbidity and mortality following abdominoperineal resection for low rectal adenocarcinoma. Rev Invest Clin (2002) 1.06
A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation. Ann Surg (2007) 1.02
Evaluation of safety of increased time interval between chemoradiation and resection for rectal cancer. Am J Surg (2006) 0.99
Can we increase the chance of sphincter saving surgery in rectal cancer with neoadjuvant treatments: lessons from a systematic review of recent randomized trials. Crit Rev Oncol Hematol (2011) 0.98
Patients with low rectal cancer treated by abdominoperineal excision have worse tumors and higher involved margin rates compared with patients treated by anterior resection. Dis Colon Rectum (2010) 0.98
Open versus robot-assisted sphincter-saving operations in rectal cancer patients: techniques and comparison of outcomes between groups of 100 matched patients. Int J Med Robot (2012) 0.98
Laparoscopic sphincter-preserving total mesorectal excision with colonic J-pouch reconstruction: five-year results. Ann Surg (2006) 0.97
Laparoscopic rectal resection with anal sphincter preservation for rectal cancer: long-term outcome. Surg Endosc (2005) 0.96
Chemoradiation instead of surgery to treat mid and low rectal tumors: is it safe? Ann Surg Oncol (2002) 0.94
Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer. Colorectal Dis (2006) 0.92
Avoiding radical surgery after pre-operative chemoradiotherapy: a possible therapeutic option in rectal cancer? Acta Oncol (2011) 0.91
Preoperative radiation therapy for locally advanced rectal cancer: a comparison between two different time intervals to surgery. Int J Colorectal Dis (2006) 0.90
Laparoscopic-assisted approach in rectal cancer patients: lessons learned from >200 patients. Surg Endosc (2004) 0.88
Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy? Acta Oncol (2010) 0.85
Changes in outcome with sphincter preserving surgery for rectal cancer in Korea, 1991-2000. Eur J Surg Oncol (2005) 0.84
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Caspase-mediated cleavage of ATG6/Beclin-1 links apoptosis to autophagy in HeLa cells. Cancer Lett (2008) 1.90
Risk factors and oncologic impact of anastomotic leakage after rectal cancer surgery. Dis Colon Rectum (2008) 1.86
Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol (2002) 1.82
lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Int J Radiat Oncol Biol Phys (2009) 1.82
Prognostic significance of lymphovascular invasion in sporadic colorectal cancer. Dis Colon Rectum (2010) 1.79
Malignant rectal obstruction within 5 cm of the anal verge: is there a role for expandable metallic stent placement? Gastrointest Endosc (2008) 1.72
Clinicopathologic characteristics of colorectal cancer patients with synchronous and metachronous gastric cancer. World J Surg (2010) 1.65
Mismatch repair status in sporadic colorectal cancer: immunohistochemistry and microsatellite instability analyses. J Gastroenterol Hepatol (2011) 1.61
CT colonography for combined colonic and extracolonic surveillance after curative resection of colorectal cancer. Radiology (2010) 1.54
Chronological improvement in survival following rectal cancer surgery: a large-scale, single-center study. World J Surg (2013) 1.45
Long-Term Outcomes of Endoscopic Versus Surgical Resection of Superficial Submucosal Colorectal Cancer. Dig Dis Sci (2015) 1.39
Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer. Cancer (2011) 1.35
Epigenetic regulation of microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer. Epigenetics (2011) 1.19
The role of colonoscopy in the diagnosis of appendicitis in patients with atypical presentations. Gastrointest Endosc (2002) 1.19
Feasibility of transanal minimally invasive surgery for mid-rectal lesions. Surg Endosc (2012) 1.15
CpG island methylation as an early event during adenoma progression in carcinogenesis of sporadic colorectal cancer. J Gastroenterol Hepatol (2005) 1.15
Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol (2007) 1.14
Clinicopathological characteristics of rectal carcinoids. Int J Colorectal Dis (2010) 1.13
Clinicopathologic features of ileocolonic malignant lymphoma: analysis according to colonoscopic classification. Gastrointest Endosc (2003) 1.10
Effectiveness of biofeedback therapy in the treatment of anterior resection syndrome after rectal cancer surgery. Dis Colon Rectum (2011) 1.08
Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol (2011) 1.07
Comparison of recurrence patterns between ≤5 years and >5 years after curative operations in colorectal cancer patients. J Surg Oncol (2013) 1.07
Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases. J Korean Surg Soc (2011) 1.04
Quality of life in colorectal cancer patients with colectomy and the validation of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C), Version 4. J Pain Symptom Manage (2005) 1.04
Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol (2011) 1.03
Diagnostic value of FDG-PET/CT for lymph node metastasis of colorectal cancer. World J Surg (2012) 0.99
Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis. Ann Surg Oncol (2011) 0.99
CT colonography for detection and characterisation of synchronous proximal colonic lesions in patients with stenosing colorectal cancer. Gut (2011) 0.99
Steroid-refractory cryptogenic multifocal ulcerous stenosing enteritis. Am J Surg (2011) 0.98
Surgical outcomes after total colectomy with ileorectal anastomosis in patients with medically intractable slow transit constipation. J Korean Soc Coloproctol (2011) 0.98
Differential expression of the LOX family genes in human colorectal adenocarcinomas. Oncol Rep (2009) 0.98
Cutoff values of preoperative s-CEA levels for predicting survivals after curative resection of colorectal cancer. J Korean Med Sci (2005) 0.96
Start codon polymorphisms in the vitamin D receptor and colorectal cancer risk. Cancer Lett (2005) 0.96
Characteristics and risk factors associated with permanent stomas after sphincter-saving resection for rectal cancer. World J Surg (2013) 0.96
Aberrant CpG island methylation in early-onset sporadic gastric carcinoma. J Cancer Res Clin Oncol (2005) 0.95
[Colonoscopic surveillance after curative resection for colorectal cancer with synchronous adenoma]. Korean J Gastroenterol (2005) 0.95
Delayed anastomotic leakage following sphincter-preserving surgery for rectal cancer. Int J Colorectal Dis (2010) 0.94
Clinicopathologic factors affecting recurrence after curative surgery for stage I colorectal cancer. J Korean Soc Coloproctol (2012) 0.94
The role of KRAS mutations in predicting the efficacy of cetuximab-plus-irinotecan therapy in irinotecan-refractory Korean metastatic colorectal cancer patients. Oncology (2009) 0.93
Clinicopathologic characteristics, surgical treatment and outcomes for splenic flexure colon cancer. Cancer Res Treat (2010) 0.93
Frequent silencing of popeye domain-containing genes, BVES and POPDC3, is associated with promoter hypermethylation in gastric cancer. Carcinogenesis (2010) 0.92
Dual-design expandable colorectal stent for malignant colorectal obstruction: comparison of flared ends and bent ends. AJR Am J Roentgenol (2009) 0.91
Small (<or= 2 cm) hepatic lesions in colorectal cancer patients: detection and characterization on mangafodipir trisodium-enhanced MRI. AJR Am J Roentgenol (2004) 0.91
Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery. J Nucl Med (2014) 0.90
Mitochondrial fragmentation caused by phenanthroline promotes mitophagy. FEBS Lett (2012) 0.90
Oncologically safe distal resection margins in rectal cancer patients treated with chemoradiotherapy. J Gastrointest Surg (2012) 0.89
Upregulation of SPRR3 promotes colorectal tumorigenesis. Mol Med (2010) 0.89
Extensive lymphadenectomy in colorectal cancer with isolated para-aortic lymph node metastasis below the level of renal vessels. J Surg Oncol (2010) 0.89
Increased expression of ATG10 in colorectal cancer is associated with lymphovascular invasion and lymph node metastasis. PLoS One (2012) 0.89
Association between deficient mismatch repair system and efficacy to irinotecan-containing chemotherapy in metastatic colon cancer. Cancer Sci (2011) 0.89
Intra-abdominal fistulas in surgically treated Crohn's disease patients. World J Surg (2010) 0.89
Risk factors for complications after bowel surgery in Korean patients with Crohn's disease. J Korean Surg Soc (2012) 0.88
CT differentiation of mucinous and nonmucinous colorectal carcinoma. AJR Am J Roentgenol (2007) 0.87
Poorly differentiated colorectal cancers: correlation of microsatellite instability with clinicopathologic features and survival. Am J Clin Pathol (2013) 0.87
Profile of methylated CpG sites of hMLH1 promoter in primary gastric carcinoma with microsatellite instability. Pathol Int (2002) 0.87
Autophagy induced by resveratrol suppresses α-MSH-induced melanogenesis. Exp Dermatol (2014) 0.87
Primary malignant melanoma of the rectum: CT findings in eight patients. Radiology (2004) 0.87
CT colonography after metallic stent placement for acute malignant colonic obstruction. Radiology (2010) 0.87
The Role of Diverting Stoma After an Ultra-low Anterior Resection for Rectal Cancer. Ann Coloproctol (2013) 0.87
Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer. Ann Surg Oncol (2007) 0.86
Region-specific changes in the immunoreactivity of SIRT1 expression in the central nervous system of SOD1(G93A) transgenic mice as an in vivo model of amyotrophic lateral sclerosis. Brain Res (2011) 0.86
Solitary preleukemic granulocytic sarcoma as a cause of small bowel obstruction. Gut Liver (2007) 0.86
CT colonography in patients who have undergone sigmoid colostomy: a feasibility study. AJR Am J Roentgenol (2011) 0.86
Palliative surgery in patients with unresectable colorectal liver metastases: a propensity score matching analysis. J Surg Oncol (2013) 0.86
Extramammary Paget's disease in Korea: its association with gastrointestinal neoplasms. Int J Colorectal Dis (2008) 0.85
Long-term outcomes in patients with locally advanced rectal cancer treated with preoperative chemoradiation followed by curative surgical resection. J Surg Oncol (2012) 0.85
Dual-design expandable colorectal stent for a malignant colorectal obstruction: preliminary prospective study using new 20-mm diameter stents. Korean J Radiol (2011) 0.85
Automated carbon dioxide insufflation for CT colonography: effectiveness of colonic distention in cancer patients with severe luminal narrowing. AJR Am J Roentgenol (2008) 0.85
Growth and invasion of sporadic colorectal adenocarcinomas in terms of genetic change. J Korean Med Sci (2010) 0.85
CT colonography for follow-up after surgery for colorectal cancer. AJR Am J Roentgenol (2007) 0.85
Adequate length of the distal resection margin in rectal cancer: from the oncological point of view. J Gastrointest Surg (2010) 0.85
Optimal time interval between capecitabine intake and radiotherapy in preoperative chemoradiation for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2006) 0.84
A receptor tyrosine kinase inhibitor, Tyrphostin A9 induces cancer cell death through Drp1 dependent mitochondria fragmentation. Biochem Biophys Res Commun (2011) 0.84
Down-regulated expression of ATG5 in colorectal cancer. Anticancer Res (2012) 0.84
Isolated diaphragmatic metastasis originated from adenocarcinoma of the colon. Cancer Res Treat (2004) 0.84
Symptomatic venous thromboembolism in Asian colorectal cancer surgery patients. World J Surg (2011) 0.84
Effects of the HDAC inhibitor CG2 in combination with irinotecan, 5-fluorouracil, or oxaliplatin on HCT116 colon cancer cells and xenografts. Oncol Rep (2010) 0.84
Failure patterns correlate with the tumor response after preoperative chemoradiotherapy for locally advanced rectal cancer. J Surg Oncol (2012) 0.84
The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models. Cancer Chemother Pharmacol (2010) 0.83
CpG island methylation in familial colorectal cancer patients not fulfilling the Amsterdam criteria. J Korean Med Sci (2008) 0.83
Prospective phase II study of preoperative chemoradiation with capecitabine in locally advanced rectal cancer. Cancer Res Treat (2004) 0.83
Clinical implication of additional selective lateral lymph node excision in patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy. Int J Colorectal Dis (2013) 0.82
Comparison of clinicopathologic characteristics and genetic alterations between microsatellite instability-positive and microsatellite instability-negative sporadic colorectal carcinomas in patients younger than 40 years old. Dis Colon Rectum (2002) 0.82
In vitro chemosensitivity of gastric adenocarcinomas to histone deacetylase inhibitors, compared to established drugs. Hepatogastroenterology (2010) 0.82
ARP101, a selective MMP-2 inhibitor, induces autophagy-associated cell death in cancer cells. Biochem Biophys Res Commun (2010) 0.82
A novel telomere elongation in an adriamycin-resistant stomach cancer cell line with decreased telomerase activity. Mol Cells (2002) 0.82
Ring finger protein 149 is an E3 ubiquitin ligase active on wild-type v-Raf murine sarcoma viral oncogene homolog B1 (BRAF). J Biol Chem (2012) 0.82
[Clinicopathologic characteristics of colorectal neuroendocrine tumor]. Korean J Gastroenterol (2006) 0.81
Reduced E-cadherin expression as a cause of distinctive signet-ring cell variant in colorectal carcinoma. J Korean Med Sci (2002) 0.81
Elevation of preoperative s-CEA concentration in stage IIA colorectal cancer can also be a high risk factor for stage II patients. Ann Surg Oncol (2013) 0.81
Prognostic implications of the number of retrieved lymph nodes of patients with rectal cancer treated with preoperative chemoradiotherapy. J Gastrointest Surg (2014) 0.80
Genetic polymorphisms of FcγRIIa and FcγRIIIa are not predictive of clinical outcomes after cetuximab plus irinotecan chemotherapy in patients with metastatic colorectal cancer. Oncology (2012) 0.80
Significance of mismatch repair protein expression in the chemotherapeutic response of sporadic invasive ductal carcinoma of the breast. Breast J (2004) 0.80
Clinicopathological characteristics of colorectal cancer with family history: an evaluation of family history as a predictive factor for microsatellite instability. J Korean Med Sci (2007) 0.80
Carnitine sensitizes TRAIL-resistant cancer cells to TRAIL-induced apoptotic cell death through the up-regulation of Bax. Biochem Biophys Res Commun (2012) 0.80
Perivascular epithelioid cell tumor of the sigmoid colon with transcription factor E3 expression. Ann Diagn Pathol (2011) 0.80
Phase II study of preoperative chemoradiation with S-1 plus oxaliplatin in patients with locally advanced rectal cancer. Cancer Sci (2012) 0.80